Could a Fat-Fighting drug sharpen minds in HIV?
NCT ID NCT02572323
Summary
This study tested whether an existing injectable medication called tesamorelin could improve memory and thinking skills in older adults living with HIV who were experiencing mild cognitive problems. Researchers enrolled 73 participants who also had excess abdominal fat, as this is linked to cognitive issues. The trial used a text-messaging app to help participants stick with their treatment schedule and measured changes in brain function over six months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MILD COGNITIVE IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
HIV Neurobehavioral Research Program (HNRP)
San Diego, California, 92103, United States
-
Keck School of Medicine of the University of Southern California
Los Angeles, California, 90033, United States
-
PalmTree
Palm Springs, California, 92262, United States
-
University of California, San Francisco
San Francisco, California, 94143, United States
Conditions
Explore the condition pages connected to this study.